Dean C. Mitchell

Dean C. Mitchell

Auto-generated profile, based on publicly available information

Dean C. Mitchell

Department of Internal Medicine , George Regional Hospital , George , South Africa

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in SA Heart
Verified
Journal Article
Closed access
DMDc Mitchell
Dc Mitchell
ADAnton Frans Doubell
Anton Frans Doubell
JMJ Moses
J Moses
Introduction: Patients with bifascicular block (BFB) are at risk of progressing to high-degree atrioventricular block (AVB) and have a higher mortality risk. This study aimed to identify relationships between clinical parameters in patients with BFB and the risk of mortality and/or requiring permanent pacemaker (PPM) insertion, to better risk-stratify and appropriately investigate patients at the time of diagnosis in a resource-limited setting. Method: A descriptive study was conducted via retrospective review of all patients who received an electrocardiogram (ECG) during 2014 at Tygerberg Hospital (TBH), South Africa. In total, 16 280 ECGs were assessed, accounting for 11 881 patients (some patients had more than 1 ECG), and those with BFB were identified. Patients’ records were assessed at the time of diagnosis and followed for 10 years to identify relationships between clinical parameters in patients with BFB and mortality or requiring a PPM. Results: Of the 11 881 patient ECGs assessed, 140 patients with BFB were identified. The mean age at diagnosis was 62 ± 17 years. Of these patients, 37 (26%) died, and 9 (6%) required a PPM. The mean age at diagnosis of demised patients was 66 ± 12 years (p = 0.07). Significant relationships with mortality included diabetes mellitus (DM) (p = 0.04) and a reduced left ventricular ejection fraction (LVEF) (p = 0.05), with age and hypertension related at a lower level of significance (p = 0.07 and p = 0.06, respectively). Significant relationships with PPM insertion were symptom presence at diagnosis (p ≤ 0.01) and PR interval prolongation at a lower level of significance (p = 0.08). Conclusion: In patients with BFB, DM, hypertension, age, and a reduced LVEF had the most significant relationships with mortality. Symptoms and a prolonged PR interval had the most significant relationships with requiring a PPM. Mortality in patients with BFB is more likely to be related to standard risk factors, such as DM, hypertension, age, and a reduced LVEF, than the conduction defect per se.

1 January 2026 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
MLMichael A. Linström
Michael A. Linström
DMDean C. Mitchell
Dean C. Mitchell
RRRiyaadh Roberts
Riyaadh Roberts
RLRobert K. Lohlun
Robert K. Lohlun
Background: Multiple primary malignant neoplasms (MPMNs) diagnosed synchronously are rare, with an incidence of less than 1%. The occurrence of triple synchronous malignancies is exceedingly uncommon, and to our knowledge, no prior reports describe the concurrent presentation of a myeloproliferative neoplasm, plasma cell dyscrasia and breast cancer. Such cases pose considerable diagnostic and therapeutic challenges, particularly in settings with limited access to advanced molecular testing and oncologic therapies. Case Presentation: A 67‐year‐old woman presented with a pathological femoral fracture, marked leucocytosis and thrombocytosis. Histological examination of the fracture site revealed a kappa‐restricted plasmacytoma meeting diagnostic criteria for multiple myeloma (R‐ISS Stage 3). Bone marrow biopsy demonstrated hypercellularity with atypical clustered megakaryocytes, consistent with prefibrotic primary myelofibrosis, and molecular analysis confirmed a JAK2 V617F mutation. During evaluation, a right breast mass was confirmed on core biopsy as an invasive carcinoma with focal mucinous differentiation (ER/PR‐positive, HER2‐negative and Ki‐67 25%), consistent with a luminal B–like profile. The patient commenced therapy with melphalan and prednisone for myeloma and anastrozole for breast carcinoma, with multidisciplinary input guiding treatment sequencing. Discussion: This case represents an exceptionally rare triad of synchronous malignancies spanning myeloid, plasma‐cell and epithelial lineages. While myeloproliferative neoplasms are associated with an elevated risk of secondary neoplasia, the simultaneous occurrence of three independent malignancies raises the possibility of shared pathogenic mechanisms such as clonal haematopoiesis or an underlying germline predisposition. The presentation highlights the diagnostic complexity of distinguishing independent primaries from metastatic disease and illustrates the importance of maintaining diagnostic vigilance. Limited access to next‐generation sequencing and novel therapies further complicates management in resource‐constrained healthcare environments. Conclusion: Triple synchronous primary malignancies are exceedingly rare and diagnostically challenging. This case emphasises the necessity of a systematic, multidisciplinary approach to evaluation and management, even in low‐resource settings, to ensure accurate diagnosis and optimal coordination of care across multiple oncologic pathologies.